Pricing Log in Create free account

Annexon, Inc. (ANNX) vs Corvus Pharmaceuticals, Inc. (CRVS)

Annexon, Inc. and Corvus Pharmaceuticals, Inc. are both Biotechnology companies. Annexon, Inc. and Corvus Pharmaceuticals, Inc. are of similar size ($818.5M and $759.3M). Across the 9 metrics below, Corvus Pharmaceuticals, Inc. leads on 7 and Annexon, Inc. on 2.

Valuation

Metric ANNX CRVS Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 4.55 4.33 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (27.55%) (5.77%) (32.88%)
Free cash flow yield (22.83%) (4.63%) (23.13%)

Profitability

Metric ANNX CRVS Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (105.26%) (35.43%) (51.96%)
Return on assets (79.38%) (32.93%) (46.06%)
Return on invested capital 0.00% (352.49%) 0.00%

Growth

Metric ANNX CRVS Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (32.67%) 48.04% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANNX CRVS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.53 16.16 4.97
Net debt to EBITDA 1.11 1.28 1.01

Dividend

Metric ANNX CRVS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ANNX CRVS Biotechnology median
Market cap 759.27m 818.50m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack